Non-Statin Therapies for Elevated LDL-C: The Role of Inclisiran (and…

Collaborative CME and Research Network

J. Genest

Familial Hypercholesterolemia: From Diagnosis to Treatment

Scripps Health

P. Duell

HID 2023 Insights: LDL-C - How Low Can We Go Safely?

Seth Martin

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

Jefferson Health

A. Cohen

Treatment of Lipids in 2023: Where Are We Now and Where Are We Going?

Houston Methodist DeBakey Heart and Vascular Center

C. Ballantyne

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

ENDO 2022: Targeting PCSK9 for LDL-C Reduction

Connie Newman

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

The Texas Heart Institute

S. Virani

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

Lipid Management & Low Carb Diets

Metabolic Health Summit

B. Scher

Non-Statin Pharmacotherapies for Risk Reduction

Scripps Health

M. Wilkinson